GlucoGuard Sleep
IMD Solutions, Inc. is a medical device company focused on addressing nocturnal hypoglycemia. Their flagship product, GlucoGuard, is an automated oral retainer device that works with existing Continuous Glucose Monitors (CGMs) and proprietary AI algorithms to predict and treat low blood sugar events during sleep. The company emphasizes ease of use, automated treatment, and peace of mind for users and their caregivers. The team has over 50 years of combined experience in the medical device industry, with a focus on development, marketing, research, engineering, and commercialization of patented medical devices. Bill Colone, a medical advisor, holds 13 US patents.
GlucoGuard Sleep
IMD Solutions, Inc. is a medical device company focused on addressing nocturnal hypoglycemia. Their flagship product, GlucoGuard, is an automated oral retainer device that works with existing Continuous Glucose Monitors (CGMs) and proprietary AI algorithms to predict and treat low blood sugar events during sleep. The company emphasizes ease of use, automated treatment, and peace of mind for users and their caregivers. The team has over 50 years of combined experience in the medical device industry, with a focus on development, marketing, research, engineering, and commercialization of patented medical devices. Bill Colone, a medical advisor, holds 13 US patents.